LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $77.00
The Cerbat Gem -

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its price objective upped by research analysts at JMP Securities from $72.00 to $77.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “market outperform” rating on the medical instruments supplier’s stock. JMP Securities’ target price indicates a potential upside of 3.75% […]

In related news